Your email has been successfully added to our mailing list.

×
-7.10176834031028E-05 -0.00169377174916546 -0.00171578723102056 -0.00461614942120592 -0.00695973297351033 -0.00653362687309131 -0.00909026347560543 -0.00972942262623396
Stock impact report

FDA moves to bring multibillion-dollar medical test industry under full government scrutiny [Fortune]

Quest Diagnostics Incorporated (DGX) 
Last quest diagnostics incorporated earnings: 4/22 06:45 am Check Earnings Report
US:NYSE Investor Relations: ir.questdiagnostics.com
Company Research Source: Fortune
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. Califf said inaccurate tests can lead to unnecessary treatment or delays in getting proper care. But in a significant move, the FDA decided that the tens of thousands of tests currently on the market will not have to undergo federal review. The agency said it will essentially grandfather those tests into approval to address concerns that the new Show less Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for DGX alerts
Opt-in for
DGX alerts

from News Quantified
Opt-in for
DGX alerts

from News Quantified